Thoma Bravo related stories
All articles and analysis
How PE learned to stop worrying and love inflationThe current debate about whether the inflation spike we are seeing is ‘transitory’ should be reframed as ‘reflation vs sustained inflation’, according to Commonfund’s Ryan Driscoll.
Side Letter: Europe's newest alts giant; PEI 300; JPMAM taps CPP vetToday's the day! This year's PEI 300 ranking is live. Plus: Europe's newest alts giant and a CPP Investments veteran has moved to JPMorgan Asset Management. Here's today's brief, for our valued subscribers only.
PEI 300 2021: Buy high, sell higher – the mid-market rolls onRising multiples have not weakened enthusiasm for a segment that has historically outperformed the rest.
PEI 300 2021: Growth equity offers best of both worldsA lot of capital is swirling around growth equity, a sign of the strategy’s growing appeal beyond buyouts and venture capital.
PEI 300 2021: Immune response to covidWhat pandemic? The industry’s 300 largest firms raised a record $2.25 trillion in fresh capital over the past five years.
PEI 300 2021: Tech cements its place at the topTechnology specialists are hot on the heels of the very largest multi-asset managers with the pandemic adding further impetus.
Future 40 Leaders – 2021: DealmakersThe 40 under 40: Future Leaders of Private Equity dealmakers honoured for their potential to make a mark on the private equity industry moving forward.
Private equity defies pandemic to raise record $180bn in Q1Fundraising looks on track for another successful year with the most raised between January-March this year than any other equivalent period post-GFC.
Side Letter: Q1's record fundraising; Thoma Bravo's target; PE sports blow?Fundraising appears to have bounced back to record levels in the first quarter. Plus: whether football's proposed European Super League could impact PE's appetite for the sport, and growth equity is living up to its name. Here's today's brief, for our valued subscribers only.
Vitruvian plan: The inside story of one of Europe’s most secretive investorsVitruvian keeps a low profile. Based on interviews with those who have invested with and worked alongside it, we discover why it is so successful.